Author: Alliance for Trade Enforcement

Did you know that Korea continues to violate its obligations under KORUS to fairly reimburse U.S. biopharmaceutical manufacturers for their new cures and treatments? For example, KORUS requires Korea to set up an independent review process for pricing determinations of new drugs...

Welcome to the third edition of Spotlight on Enforcement, where every other week the Alliance for Trade Enforcement will highlight the various ways that other countries are not fulfilling their commitments to American companies and workers...